Acne treatment works best when medicines match the type and severity of the lesions. Patients and families should expect a stepwise plan, consistent use, and scheduled reviews rather than an immediate cure. Topical medicines treat many cases, while oral antibiotics, hormonal therapy, or isotretinoin may be appropriate in specific situations. Each option has different benefits, limits, and safety requirements.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How clinicians choose a treatment
- What topical medicines do
- When oral antibiotics enter the plan
- Who may benefit from hormonal treatment
- Isotretinoin requires strict safeguards
How clinicians choose a treatment
A clinician first considers lesion type, severity, age, and which treatments have already been tried. The American Academy of Dermatology strongly recommends benzoyl peroxide, topical retinoids, antibiotics, and combinations of these treatments for patients age 9 and older, with the choice individualized to the patient in its updated acne guidelines.
A practical treatment plan should answer four questions: Families should understand that moving to a stronger or oral treatment is not automatic. The decision depends on acne severity, treatment response, safety considerations, and the areas that need treatment.
- Which medicine targets the patient's acne?
- Should topical medicines be combined?
- Is an oral medicine necessary?
- When will the clinician review the response?
What topical medicines do
Topical retinoids, including adapalene and tretinoin, help unclog pores and reduce inflammation. Benzoyl peroxide reduces acne-causing bacteria. Using medicines with different actions can address more than one acne mechanism, as explained in the American Academy of Dermatology's patient treatment guidance.
Consistency matters because results develop gradually. The American Academy of Dermatology advises that fewer breakouts commonly appear after four to eight weeks, while clearer skin may take about 16 weeks. This timeline helps families judge progress fairly. A patient who sees little change after several days has not necessarily failed treatment, but the medicine still needs to be used as directed.
When oral antibiotics enter the plan
For moderate-to-severe acne, a clinician may add an oral antibiotic such as doxycycline to topical treatment. Oral medicine can reach difficult areas, including the back, but it can also cause systemic adverse effects and contribute to antibiotic resistance. Antibiotics should not be used alone for acne.
NICE recommends pairing them with appropriate topical treatment, reviewing the initial regimen at 12 weeks, and stopping an oral antibiotic once acne has cleared while continuing topical therapy in its acne management recommendations. Antibiotic-containing treatment beyond six months should be exceptional. At each review, patients can ask whether the antibiotic is still necessary and which topical treatment should continue afterward.
Who may benefit from hormonal treatment
Some patients have acne with hormonal drivers. Dermatologists may consider a combined oral contraceptive or spironolactone in these cases.
The American Academy of Dermatology classifies both options as conditional recommendations. That means they require a patient-specific decision rather than serving as standard treatment for everyone. Patients and families should ask why hormonal therapy fits the acne pattern, what other options are available, and how the clinician will judge whether it is working.
Isotretinoin requires strict safeguards
Isotretinoin is reserved for severe, treatment-resistant nodular acne in non-pregnant patients age 12 or older. It is not a routine substitute for topical treatment or a short antibiotic course. Pregnancy exposure can cause life-threatening birth defects, even when exposure is brief.
The medication is therefore contraindicated during pregnancy and available only through the iPLEDGE REMS program, according to the DailyMed isotretinoin label. Patients who can become pregnant must have two negative pregnancy tests before treatment and monthly testing during treatment. They must follow pregnancy-prevention requirements through one month after the final dose.
